Is gSTP1 promoter methylation associated with recurrence in early stage prostate cancer?
Greater GSTP1 promoter methylation in cancer tissue was independently associated with the risk of recurrence in patients with early prostate cancer. This suggests that GSTP1 promoter methylation may be a potential tissue based recurrence marker.
Targeting the Twist box domain of Twist1 may effectively limit prostate cancer metastatic potential.